Trial Outcomes & Findings for Treatment of Stress Urinary Incontinence Via Smartphone (NCT NCT01848938)

NCT ID: NCT01848938

Last Updated: 2017-04-05

Results Overview

Three items on frequency, amount of leakage and overall impact. Scoring 0-21, higher values indicating increasing severity

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

123 participants

Primary outcome timeframe

baseline, three months

Results posted on

2017-04-05

Participant Flow

We recruited community-dwelling women, from March 2013 to October 2014, through our website. Interested women filled out a questionnaire to determine whether they met the study criteria. Eligible women received a letter with informed consent and a 2-day leakage diary, and after returning this they also answered a web-based questionnaire.

Randomisation was performed by concealing the allocations in sequentially numbered, opaque, sealed envelopes. An independent administrator generated the allocation sequence and prepared 130 envelopes. The study coordinator opened one envelope for each participant and assigned an e-mail, with materials for the corresponding study group.

Participant milestones

Participant milestones
Measure
Smartphone Treatment
Smartphone treatment with PFMT. Smartphone treatment with PFMT: A smartphone application with information on SUI, life style information, different programmes of PFMT with increasing severity, possibility to save statistics on training. Possibility to set reminders. The treatment period is three months
Waiting List
Waiting list for three months. They receive the smartphone application after follow-up.
Overall Study
STARTED
62
61
Overall Study
COMPLETED
61
60
Overall Study
NOT COMPLETED
1
1

Reasons for withdrawal

Reasons for withdrawal
Measure
Smartphone Treatment
Smartphone treatment with PFMT. Smartphone treatment with PFMT: A smartphone application with information on SUI, life style information, different programmes of PFMT with increasing severity, possibility to save statistics on training. Possibility to set reminders. The treatment period is three months
Waiting List
Waiting list for three months. They receive the smartphone application after follow-up.
Overall Study
Lost to Follow-up
1
1

Baseline Characteristics

Treatment of Stress Urinary Incontinence Via Smartphone

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Smartphone Treatment
n=62 Participants
Smartphone treatment with pelvic floor muscle training (PFMT). Smartphone treatment with PFMT: A smartphone application with information on SUI, life style information, different programmes of PFMT with increasing severity, possibility to save statistics on training. Possibility to set reminders. The treatment period is three months
Waiting List
n=61 Participants
Waiting list for three months. They receive the smartphone application after follow-up.
Total
n=123 Participants
Total of all reporting groups
Age, Continuous
44.8 years
STANDARD_DEVIATION 9.7 • n=5 Participants
44.7 years
STANDARD_DEVIATION 9.1 • n=7 Participants
44.7 years
STANDARD_DEVIATION 9.4 • n=5 Participants
Sex: Female, Male
Female
62 Participants
n=5 Participants
61 Participants
n=7 Participants
123 Participants
n=5 Participants
Sex: Female, Male
Male
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Region of Enrollment
Sweden
62 Participants
n=5 Participants
61 Participants
n=7 Participants
123 Participants
n=5 Participants
Body Mass Index
24.0 kg/m^2
STANDARD_DEVIATION 4.1 • n=5 Participants
24.5 kg/m^2
STANDARD_DEVIATION 4.4 • n=7 Participants
24.2 kg/m^2
STANDARD_DEVIATION 4.2 • n=5 Participants
Smoking
smoker
2 participants
n=5 Participants
3 participants
n=7 Participants
5 participants
n=5 Participants
Smoking
non-smoker
60 participants
n=5 Participants
58 participants
n=7 Participants
118 participants
n=5 Participants
Education
>=3 years at university level
52 participants
n=5 Participants
46 participants
n=7 Participants
98 participants
n=5 Participants
Education
<3 years at university level
10 participants
n=5 Participants
15 participants
n=7 Participants
25 participants
n=5 Participants
Parity
nulliparous
5 participants
n=5 Participants
4 participants
n=7 Participants
9 participants
n=5 Participants
Parity
not nulliparous
57 participants
n=5 Participants
57 participants
n=7 Participants
114 participants
n=5 Participants
Regular Medication
on regular medication
28 participants
n=5 Participants
24 participants
n=7 Participants
52 participants
n=5 Participants
Regular Medication
no regular medication
34 participants
n=5 Participants
37 participants
n=7 Participants
71 participants
n=5 Participants
Usage of incontinence aids
No use
6 participants
n=5 Participants
10 participants
n=7 Participants
16 participants
n=5 Participants
Usage of incontinence aids
Less than once a week
13 participants
n=5 Participants
14 participants
n=7 Participants
27 participants
n=5 Participants
Usage of incontinence aids
1-3 times/week
19 participants
n=5 Participants
18 participants
n=7 Participants
37 participants
n=5 Participants
Usage of incontinence aids
>3 times/week, but not daily
11 participants
n=5 Participants
5 participants
n=7 Participants
16 participants
n=5 Participants
Usage of incontinence aids
1 aid a day
9 participants
n=5 Participants
10 participants
n=7 Participants
19 participants
n=5 Participants
Usage of incontinence aids
More than 1 aid a day
4 participants
n=5 Participants
4 participants
n=7 Participants
8 participants
n=5 Participants

PRIMARY outcome

Timeframe: baseline, three months

Population: intention-to-treat analysis

Three items on frequency, amount of leakage and overall impact. Scoring 0-21, higher values indicating increasing severity

Outcome measures

Outcome measures
Measure
Smartphone Treatment
n=62 Participants
Smartphone treatment with PFMT. Smartphone treatment with PFMT: A smartphone application with information on SUI, life style information, different programmes of PFMT with increasing severity, possibility to save statistics on training. Possibility to set reminders. The treatment period is three months
Waiting List
n=61 Participants
Waiting list for three months. They receive the smartphone application after follow-up.
International Consultation on Incontinence Modular Questionnaire Urinary Incontinence Short Form (ICIQ-UI SF)
baseline
11.1 units on a scale
Standard Deviation 3.0
11.0 units on a scale
Standard Deviation 2.6
International Consultation on Incontinence Modular Questionnaire Urinary Incontinence Short Form (ICIQ-UI SF)
3 month follow-up
7.0 units on a scale
Standard Deviation 3.5
10.2 units on a scale
Standard Deviation 3.2

PRIMARY outcome

Timeframe: baseline, three months

Population: intention-to-treat analysis

The instrument includes 19 items on the impact of the leakage. All items are scored 1-4 (not at all/never, slightly/sometimes, moderately/often, a lot/all the time). The overall score is 19-76, with higher values indicating increased impact on QOL.

Outcome measures

Outcome measures
Measure
Smartphone Treatment
n=62 Participants
Smartphone treatment with PFMT. Smartphone treatment with PFMT: A smartphone application with information on SUI, life style information, different programmes of PFMT with increasing severity, possibility to save statistics on training. Possibility to set reminders. The treatment period is three months
Waiting List
n=61 Participants
Waiting list for three months. They receive the smartphone application after follow-up.
International Consultation on Incontinence Modular Questionnaire Lower Urinary Tract Symptoms Quality of Life (ICIQ-LUTSqol)
baseline
34.1 units on a scale
Standard Deviation 6.1
34.8 units on a scale
Standard Deviation 6.1
International Consultation on Incontinence Modular Questionnaire Lower Urinary Tract Symptoms Quality of Life (ICIQ-LUTSqol)
3 month follow-up
28.8 units on a scale
Standard Deviation 6.4
34.1 units on a scale
Standard Deviation 6.7

SECONDARY outcome

Timeframe: three months

Population: intention-to-treat analysis. Missing values at follow-up were replaced with the corresponding values at baseline (i.e., no change).

Usage of incontinence aids during the last 4 weeks.

Outcome measures

Outcome measures
Measure
Smartphone Treatment
n=62 Participants
Smartphone treatment with PFMT. Smartphone treatment with PFMT: A smartphone application with information on SUI, life style information, different programmes of PFMT with increasing severity, possibility to save statistics on training. Possibility to set reminders. The treatment period is three months
Waiting List
n=61 Participants
Waiting list for three months. They receive the smartphone application after follow-up.
Usage of Incontinence Aids
No use
23 participants
14 participants
Usage of Incontinence Aids
Less than once a week
13 participants
11 participants
Usage of Incontinence Aids
1-3 times/week
10 participants
13 participants
Usage of Incontinence Aids
>3 times/week, but not daily
5 participants
4 participants
Usage of Incontinence Aids
1 aid a day
8 participants
12 participants
Usage of Incontinence Aids
More than 1 aid a day
2 participants
6 participants

SECONDARY outcome

Timeframe: three months

Population: Data for this outcome measure could only be collected for the smartphone treatment group.

A self-rated question about if the current treatment was sufficient, with three response options

Outcome measures

Outcome measures
Measure
Smartphone Treatment
n=60 Participants
Smartphone treatment with PFMT. Smartphone treatment with PFMT: A smartphone application with information on SUI, life style information, different programmes of PFMT with increasing severity, possibility to save statistics on training. Possibility to set reminders. The treatment period is three months
Waiting List
Waiting list for three months. They receive the smartphone application after follow-up.
Patient Satisfaction
Yes, I am completely free of leakage
5 participants
Patient Satisfaction
Yes, sufficient, although I am not completely free
35 participants
Patient Satisfaction
No
20 participants

SECONDARY outcome

Timeframe: baseline, three months

Population: intention-to-treat analysis. Missing values at follow-up were replaced with the corresponding values at baseline (i.e., no change).

number of incontinence episodes per week

Outcome measures

Outcome measures
Measure
Smartphone Treatment
n=62 Participants
Smartphone treatment with PFMT. Smartphone treatment with PFMT: A smartphone application with information on SUI, life style information, different programmes of PFMT with increasing severity, possibility to save statistics on training. Possibility to set reminders. The treatment period is three months
Waiting List
n=61 Participants
Waiting list for three months. They receive the smartphone application after follow-up.
Incontinence Episode Frequency (IEF)
baseline
21.0 episodes per week
Interval 10.5 to 28.0
17.5 episodes per week
Interval 10.5 to 24.5
Incontinence Episode Frequency (IEF)
three month follow-up
7 episodes per week
Interval 0.0 to 14.0
14 episodes per week
Interval 7.0 to 26.0

SECONDARY outcome

Timeframe: three months

Population: intention-to-treat analysis. Missing values at follow-up were replaced with a neutral value (i.e., no change).

A self-rated question that asks about the change experienced after treatment with 7 response options, ranging from "very much better" to "very much worse".

Outcome measures

Outcome measures
Measure
Smartphone Treatment
n=62 Participants
Smartphone treatment with PFMT. Smartphone treatment with PFMT: A smartphone application with information on SUI, life style information, different programmes of PFMT with increasing severity, possibility to save statistics on training. Possibility to set reminders. The treatment period is three months
Waiting List
n=61 Participants
Waiting list for three months. They receive the smartphone application after follow-up.
Patient's Global Impression of Improvement Scale (PGI-I)
very much better
6 participants
0 participants
Patient's Global Impression of Improvement Scale (PGI-I)
much better
28 participants
3 participants
Patient's Global Impression of Improvement Scale (PGI-I)
a little better
22 participants
9 participants
Patient's Global Impression of Improvement Scale (PGI-I)
no change
5 participants
42 participants
Patient's Global Impression of Improvement Scale (PGI-I)
a little worse
0 participants
6 participants
Patient's Global Impression of Improvement Scale (PGI-I)
much worse
0 participants
0 participants
Patient's Global Impression of Improvement Scale (PGI-I)
very much worse
0 participants
0 participants

Adverse Events

Smartphone Treatment

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Waiting List

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Eva Samuelsson

Umeå University, Umeå, Sweden

Phone: +46706966440

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place